A branching process model of drug resistant HIV

Deterministic and Stochastic Models of AIDS Epidemics and HIV Infections with Intervention

Volumn , Issue , 2005, Pages 457-496

  Zhou, H ^a   Dorman, K S ^a  

^a NONE

Author keywords

Branching process; Drug resistance; Stochastic model

Indexed keywords

EID: 84967520844     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812569264_0018     Document Type: Chapter

References (36)

1. Anderson RM and May RM (1991) Infectious Diseases in Humans: Dynamics and Control. Clarendon, Oxford.
2. Bonhoeffer S, May RM, Shaw GM and Nowak MA (1997) Models of virus dynamics and drug therapy. Proc Natl Acad Sci USA 94: 6971-6976.
3. Casella G and Berger RL (2001) Statistical Inference, pp. 244, Belmont, California.
4. Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH and Shaw GM (1991) High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. New Eng J Med, 324: 954-960.
5. Coffin JM (1995) HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267: 482-489.
6. Cohen J (2002) Confronting the limits of success. Science 296: 2320-2324.
7. Daar ES, Moudgil T, Meyer RD and Ho DD (1991) Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. New Eng J Med 324: 961-964.
8. Dorman KS, Sinsheimer JS and Lange K (2004) In the garden of branching processes. SIAM Rev, in press.
9. Finzi D and Blankson J and Siliciano JD and Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J and Siliciano RF (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5: 512-517.
10. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM and Markowitz M (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373: 123-126.
11. de Jong MD, Veenstra J, Stilianakis NI, Schuurman R, Lange JM, de Boer RJ and Boucher CA (1996) Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine. Proc Natl Acad Sci USA 93: 5501-5506.
12. Haase AT (1999) Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Ann Rev Immunol 17: 625-656.
13. Henrard DR, Daar E, Farzadegan H, Clark SJ, Phillips J, Shaw GM and Busch MP (1995) Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 9: 305-310.
14. Kamina A, Makuch RW and Zhao H (2001) A stochastic modeling of early HIV-1 population dynamics. Math Biosci 170: 187-198.
15. Klarmann GJ, Schauber CA and Preston BD (1993) Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro. J Biol Chem 268: 9793-9802.
16. Klenerman P, Phillips RE, Rinaldo CR, Wahl LM, Ogg G, May RM, McMichael AJ and Nowak MA (1996) Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc Natl Acad Sci USA 93: 15323-15328.
17. Mammano F, Trouplin V, Zennou V and Clavel F (2000) Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drugs. J Virol 74: 8524-8531.
18. Mansky LM and Temin HM (1995) Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 29: 5087-5094.
19. Mansky LM (1996) Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line. AIDS Res Hum Retrovir 12: 307-314.
20. Markowitz M, Louie M, Hurley A, Sun E, Mascio MD, Perelson AS and Ho DD (2003) A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J Virol 77: 5037-5038.
21. Nowak MA, Anderson RM, Boerlijst MC, Bonhoeffer S, May RM and McMichael AJ (1996) HIV evolution and disease progression. Science 274: 1008-1011.
22. Perelson AS, Neumann AU, Markowitz M, Leonard JM and Ho DD (1996). HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582-1586.
23. Phillips AN (1996) Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271: 497-499.
24. Pomerantz RJ and Horn DL (2003) Twenty years of therapy for HIV-1 infection. Nat Med 9: 867-873.
25. Reimann KA, Tenner-Racz K, Racz P, Montefiori DC, Yasutomi Y, Lin W, Ransil BJ and Letvin NL (1994) Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 68: 2362-2370.
26. Ribeiro RM, Bonhoeffer S and Nowak M (1998) The frequency of resistant mutant virus before antiviral therapy. AIDS 12: 461-465.
27. Ribeiro RM and Bonhoeffer S (2000) Production of resistant HIV mutants during antiretroviral therapy. Proc Natl Acad Sci USA 97: 7681-7685.
28. Ricchetti M and Buc H (1990) Reverse transcriptases and genomic variability: the accuracy of DNA replication is enzyme specific and sequence dependent. EMBO J 9: 1583-1593.
29. Saksena NK and Potter SJ (2003) Reservoirs of HIV-1 in vivo: implications for antiretroviral therapy. AIDS Rev 5: 3-18.
30. Schacker TW, Hughes JP, Shea T, Coombs RW and Corey L (1998) Biological and virologic characteristics of primary HIV infection. Ann Intern Med 128: 613-620.
31. Shafer RW (2002) Genotypic testing for human immunodeficiency virus type 1 drug resistance. Clin Microbiol Rev 15: 247-177.
32. Sodora DL, Lee F, Dailey PJ and Marx PA (1998) A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route. AIDS Res Hum Retrovir 14: 171-181.
33. Tsai CC, Follis KE, Grant RF, Nolte RE, Wu H and Benveniste RE (1993) Infectivity and pathogenesis of titered dosages of simian immunodeficiency virus experimentally inoculated into longtailed macaques (Macaca fascicularis). Lab Anim Sci 43: 411-416.
34. Tuckwell HC and Le Corfec E (1998) A stochastic model for early HIV-1 population dynamics. J Theor Biol 195: 451-463.
35. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS and Shaw GM (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373: 117-122.
36. Zhou H (2003). Branching process models for HIV-1 drug resistant mutants, M. Sci. Thesis, Interdepartmental Program in Bioinformatics and Computational Biology, Iowa State Univ., 106p.